25 Pharma Startups in Germany to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Diagnosis and treatment of hard-to-treat cancers. |
$24M · Series A | Earlybird Venture Capital, Andera Partners, HealthCap | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Berlin, Germany | •••••••••••@ariceum-therapeutics.com | |
Pioneer in precision medicine for psychiatry based in Munich. |
$10M | ALSTIN Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B | Munich, Germany | •••••••••••@hmnc-brainhealth.com | |
Platform that uses AI to improve diagnostics in pathology, aiding drug development and clinical research. |
$5M · Seed | High-Tech Gründerfonds, Ascension Ventures, Wellington Partners | 11 to 50 | Health Tech, AI, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Berlin, Germany | •••••••••••@aignostics.com | |
Platform ensuring transparent and secure supply chains in life sciences at affordable costs. |
$12M · Series A | HV Capital, Cherry Ventures, H14 | 11 to 50 | AI, Pharma, Business Intelligence | B2B, Marketplace | Frankfurt, Germany | •••••••••••@qualifyze.com | |
Solution against constipation using natural preparations. |
$3M · Seed | Calm/Storm Ventures | 1 to 10 | Health Tech, Foodtech, Pharma, Manufacturing | B2B | Berlin, Germany | •••••••••••@apriwell.de | |
Platform that connects patients and pharmaceutical companies to improve health outcomes. |
$2M · Seed | Aescuvest | 11 to 50 | Health Tech, Pharma, Sales and Marketing | B2B, Marketplace | Munich, Germany | •••••••••••@xo-life.com | |
Platform for discovering and developing medicines to treat and prevent heart disease. |
$76M | BioMedPartners, High-Tech Gründerfonds, Inkef Capital | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Hanover, Germany | •••••••••••@cardior.de | |
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need. |
$99M | High-Tech Gründerfonds, Hadean Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Fitness, Manufacturing | B2B | Duisburg, Germany | •••••••••••@emergencetx.com | |
Platform for clinical validation and product surveillance of medical devices and pharmaceutical products. |
$1M · Pre Seed | Nauta Capital | 51 to 100 | Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Munich, Germany | •••••••••••@climedo.de | |
protein engineering, ML, drug development |
N/A | Entrepreneur First, Picus Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Machine Learning, Pharma | B2B | Berlin, Germany | •••••••••••@cinference.bio | |
Biotechnology firm leveraging AI to expedite molecule creation. |
N/A | Picus Capital | 1 to 10 | AI, Biotech, Pharma, Business Intelligence | B2B | Munich, Germany | •••••••••••@molab.ai | |
Developer of new immuno-virotherapies focused on treating cancer. |
$13M · Series A | High-Tech Gründerfonds, Seventure Partners, Coparion | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Essen, Germany | •••••••••••@abalos-tx.com | |
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development. |
$10M · Series A | Andera Partners | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Heidelberg, Germany | •••••••••••@exciva.com | |
Neuroscience company focused on developing drugs at the preclinical stage. |
$10M | High-Tech Gründerfonds, Coparion | Health Tech, Pharma, Manufacturing | B2B | Heidelberg, Germany | •••••••••••@fundamentalpharma.com | ||
Platform that transforms unstructured data into structured, understandable insights. |
$5M · Series A | Fly Ventures, btov Partners | 11 to 50 | Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Bielefeld, Germany | •••••••••••@semalytix.com | |
Biotechnology company that develops novel biological therapies. |
$73M | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Freiburg, Germany | •••••••••••@elevabiologics.com | ||
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases. |
$4M · Series B | Aescap Venture, EMBL Ventures | 11 to 50 | Biotech, Pharma | B2C | Dortmund, Germany | •••••••••••@affectis.com | |
Platform developing quantum algorithms to predict molecular properties for specialty chemicals and pharmaceutical companies. |
$2M · Seed | Quantonation, btov Partners, High-Tech Gründerfonds | 1 to 10 | Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Karlsruhe, Germany | •••••••••••@quantumsimulations.de | |
Application offering instant delivery services for local pharmacies. |
N/A | 11 to 50 | Health Tech, CPG & Consumer Goods, Pharma, Mobile, Food Delivery, Ecommerce | B2C, Marketplace | Berlin, Germany | •••••••••••@first-a.de | ||
Screening technology that uses artificial intelligence for non-invasive detection of coronary and structural heart diseases. |
$4M · Seed | 11 to 50 | Health Tech, Pharma | B2B, B2C | Frankfurt, Germany | •••••••••••@cardis.io | ||
Platform enabling rapid, plant-based, cell-free protein expression for research, development, and production. |
$13M · Series A | 11 to 50 | Biotech, Deep Tech, Pharma, Manufacturing | B2B | Düsseldorf, Germany | •••••••••••@leniobio.com | ||
Diagnostics company specializing in identifying infections quickly. |
N/A | Earlybird Venture Capital, High-Tech Gründerfonds, Paua Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Duisburg, Germany | •••••••••••@noscendo.com | |
Cream for moisturizing care against vulva dryness. |
N/A | 11 to 50 | Health Tech, Pharma, Manufacturing, Ecommerce | B2C | Cologne, Germany | •••••••••••@vivienkarl.com | ||
Therapeutics platform creating proteins and antibodies with human-like glycosylation. |
N/A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Cologne, Germany | •••••••••••@cevec.com | ||
Cell culture solutions provider for regenerative medicine. |
$8M · Series A | Better Ventures, b.value AG, TechVision Fonds | 11 to 50 | Biotech, Pharma | B2B | Aachen, Germany | •••••••••••@pl-bioscience.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.